Cite
MLA Citation
Y. Allanore et al.. “OP0250 EFFICACY AND SAFETY OF ROMILKIMAB IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC): RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 24-WEEK, PROOF OF CONCEPT STUDY.” Annals of the rheumatic diseases, vol. 79, n.d., pp. 157–158. http://access.bl.uk/ark:/81055/vdc_100144725279.0x00004a